Position in AEON
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$14,397
-$5,326 QoQ
Shares Held
20,024
0.0% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 22 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AEON Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Formidable Asset Management, LLC holds $7,832,997 across 10 Biotechnology names. AEON ranks #10 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
64,099 | $2,500,501 | |
| 2 | RPRX |
Royalty Pharma plc
|
32,010 | $1,794,800 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,518 | $1,747,496 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
7,828 | $680,644 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
847 | $528,138 | |
| 6 | TECH |
BIO-TECHNE Corp
|
5,017 | $354,451 | |
| 7 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
11,700 | $78,624 | |
| 8 | HELP |
Cybin Inc.
|
10,217 | $67,534 |
All Filings in AEON
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,397 | 20,024 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $19,723 | 20,024 | Shares | Sole | 2026-04-22 | |
| 2024-12-31 | $372,158 | 689,182 | Shares | Sole | 2025-02-19 | |
| 2024-09-30 | $409,271 | 389,782 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $119,325 | 113,643 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $791,038 | 68,193 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $418,989 | 58,193 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $360,141 | 64,311 | Shares | Sole | 2023-11-09 | |
| No filing history on record for this holder in this stock. | ||||||